Ticlopidine increases the AUC of
bupropion by about 80% and decreases the AUC of its active
metabolite, hydroxybupropion, by about 80%.
Dose adjustments may be needed. It would seem prudent to monitor for increased
bupropion adverse effects (lightheadedness,
gastrointestinal effects) and
efficacy.